Cost-effectiveness analysis of low density lipoprotein cholesterol-lowering therapy in hypertensive patients with type 2 diabetes in Korea: single-pill regimen (amlodipine/atorvastatin) versus double-pill regimen (amlodipine+atorvastatin)

MLA

Ji-Hyun Park, et al. “Cost-Effectiveness Analysis of Low Density Lipoprotein Cholesterol-Lowering Therapy in Hypertensive Patients with Type 2 Diabetes in Korea: Single-Pill Regimen (Amlodipine/Atorvastatin) versus Double-Pill Regimen (Amlodipine+atorvastatin).” Epidemiology and Health, vol. 37, Feb. 2015. EBSCOhost, https://doi.org/10.4178/epih/e2015010.

APA

Ji-Hyun Park, Yong-Ho Lee, Su-Kyoung Ko, & Bong-Soo Cha. (2015). Cost-effectiveness analysis of low density lipoprotein cholesterol-lowering therapy in hypertensive patients with type 2 diabetes in Korea: single-pill regimen (amlodipine/atorvastatin) versus double-pill regimen (amlodipine+atorvastatin). Epidemiology and Health, 37. https://doi.org/10.4178/epih/e2015010

Chicago

Ji-Hyun Park, Yong-Ho Lee, Su-Kyoung Ko, and Bong-Soo Cha. 2015. “Cost-Effectiveness Analysis of Low Density Lipoprotein Cholesterol-Lowering Therapy in Hypertensive Patients with Type 2 Diabetes in Korea: Single-Pill Regimen (Amlodipine/Atorvastatin) versus Double-Pill Regimen (Amlodipine+atorvastatin).” Epidemiology and Health 37 (February). doi:10.4178/epih/e2015010.